Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8259 | 1201 | 37.6 | 71% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BASOPHILS | Author keyword | 71 | 32% | 16% | 187 |
2 | BASOPHIL | Author keyword | 35 | 29% | 8% | 101 |
3 | HUMAN BASOPHILS | Author keyword | 23 | 70% | 2% | 19 |
4 | CD203C | Author keyword | 21 | 46% | 3% | 33 |
5 | CD63 | Author keyword | 11 | 20% | 4% | 50 |
6 | HISTAMINE RELEASE | Author keyword | 9 | 13% | 6% | 67 |
7 | UNIT OFF 2 | Address | 9 | 83% | 0% | 5 |
8 | HISTAMINE RELEASING FACTOR | Author keyword | 9 | 48% | 1% | 13 |
9 | CAST ELISA | Author keyword | 8 | 100% | 0% | 5 |
10 | BASOPHIL ACTIVATION | Author keyword | 5 | 23% | 2% | 19 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BASOPHILS | 71 | 32% | 16% | 187 | Search BASOPHILS | Search BASOPHILS |
2 | BASOPHIL | 35 | 29% | 8% | 101 | Search BASOPHIL | Search BASOPHIL |
3 | HUMAN BASOPHILS | 23 | 70% | 2% | 19 | Search HUMAN+BASOPHILS | Search HUMAN+BASOPHILS |
4 | CD203C | 21 | 46% | 3% | 33 | Search CD203C | Search CD203C |
5 | CD63 | 11 | 20% | 4% | 50 | Search CD63 | Search CD63 |
6 | HISTAMINE RELEASE | 9 | 13% | 6% | 67 | Search HISTAMINE+RELEASE | Search HISTAMINE+RELEASE |
7 | HISTAMINE RELEASING FACTOR | 9 | 48% | 1% | 13 | Search HISTAMINE+RELEASING+FACTOR | Search HISTAMINE+RELEASING+FACTOR |
8 | CAST ELISA | 8 | 100% | 0% | 5 | Search CAST+ELISA | Search CAST+ELISA |
9 | BASOPHIL ACTIVATION | 5 | 23% | 2% | 19 | Search BASOPHIL+ACTIVATION | Search BASOPHIL+ACTIVATION |
10 | E NPP3 | 5 | 63% | 0% | 5 | Search E+NPP3 | Search E+NPP3 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN BLOOD BASOPHILS | 46 | 65% | 4% | 44 |
2 | NONRELEASING HUMAN BASOPHILS | 38 | 86% | 2% | 19 |
3 | CHRONIC ALLERGIC INFLAMMATION | 28 | 62% | 2% | 29 |
4 | RELEASABILITY | 23 | 47% | 3% | 37 |
5 | ANTIBODY 97A6 | 23 | 70% | 2% | 19 |
6 | LATE PHASE RESPONSE | 22 | 55% | 2% | 28 |
7 | ACTIVITY HRA | 17 | 79% | 1% | 11 |
8 | IGE MEDIATED STIMULATION | 17 | 70% | 1% | 14 |
9 | BLOOD BASOPHILS | 17 | 47% | 2% | 26 |
10 | ARACHIDONIC ACID GENERATION | 17 | 100% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mast cells and basophils in cutaneous immune responses | 2015 | 4 | 89 | 28% |
Nonredundant Roles of Basophils in Immunity | 2011 | 54 | 107 | 54% |
Basophils have emerged as a key player in immunity | 2014 | 7 | 63 | 60% |
Protective and pathological roles of mast cells and basophils | 2013 | 51 | 153 | 30% |
Emerging Role of Human Basophil Biology in Health and Disease | 2014 | 5 | 79 | 57% |
Basophils: emerging roles in the pathogenesis of allergic disease | 2011 | 32 | 117 | 55% |
Newly appreciated roles for basophils in allergy and protective immunity | 2011 | 21 | 74 | 66% |
Basophils in allergic immune responses | 2011 | 15 | 47 | 77% |
The 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity | 2006 | 47 | 78 | 67% |
Flow-assisted allergy diagnosis: current applications and future perspectives | 2006 | 73 | 83 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT OFF 2 | 9 | 83% | 0.4% | 5 |
2 | PATHOL P ALLERGOL | 3 | 100% | 0.2% | 3 |
3 | CELLULAR ALLERGOL | 3 | 28% | 0.7% | 8 |
4 | IMMUNOL ALLERGOL RHEUMATOL | 2 | 15% | 1.2% | 14 |
5 | ABORAT DEV INNOVATIOIN SEEDS | 1 | 100% | 0.2% | 2 |
6 | ALLERG DIS CONTROL PREVENT | 1 | 100% | 0.2% | 2 |
7 | ALLERGY AEROBIOL | 1 | 40% | 0.2% | 2 |
8 | SERV MED INTERNE ALLERGOL | 1 | 33% | 0.2% | 2 |
9 | 7512 | 1 | 50% | 0.1% | 1 |
10 | ALLERGY ENVIRONM GRP | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000227074 | CHARCOT LEYDEN CRYSTALS//PIECEMEAL DEGRANULATION//ANAPHYLACTIC DEGRANULATION |
2 | 0.0000184382 | SKIN CHAMBER//LATE PHASE REACTIONS//CUTANEOUS ALLERGIC REACTIONS |
3 | 0.0000143637 | BASOPHILIC LEUKEMIA CELL//SECT CHEM IMMUNOL//RBL 2H3 CELLS |
4 | 0.0000121248 | TCTP//TRANSLATIONALLY CONTROLLED TUMOR PROTEIN//TRANSLATIONALLY CONTROLLED TUMOR PROTEIN TCTP |
5 | 0.0000119954 | OMALIZUMAB//ANTI IGE//ANTI IMMUNOGLOBULIN E |
6 | 0.0000111347 | BACTERIAL IMMUNOTHERAPY//ASTHMA AND INFECTION//BACTERIAL ALLERGY |
7 | 0.0000103473 | CHYMASE//TRYPTASE//CHYMASE INHIBITOR |
8 | 0.0000099519 | MOL INFLAMMAT SECT//FC EPSILON RI//HUMAN LUNG MAST CELL |
9 | 0.0000074213 | ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENTS//ANTI VZV ANTIBODIES//CRSSAIPSC |
10 | 0.0000073443 | DEK//ACUTE BASOPHILIC LEUKEMIA//DEK CAN |